MARKET

MRK

MRK

Merck & Co
NYSE
121.53
+0.01
+0.01%
Opening 14:26 03/18 EDT
OPEN
121.83
PREV CLOSE
121.52
HIGH
122.51
LOW
121.21
VOLUME
3.41M
TURNOVER
0
52 WEEK HIGH
130.24
52 WEEK LOW
97.81
MARKET CAP
307.79B
P/E (TTM)
848.08
1D
5D
1M
3M
1Y
5Y
IXJ: Healthcare Sector Dashboard For March
IShares Global Healthcare ETF is overvalued by about 13% relative to 11-year averages. Healthcare equipment has the worst value and quality scores. The healthcare sector is the most overvalued in the U.S. In March 2024. This monthly article series shows a dashboard with aggregate industry metrics in healthcare.
Seeking Alpha · 12h ago
U.S. CDC Issues Health Alert Network Health Advisory On Increase In Global And Domestic Measles Cases And Outbreaks; Says Ensure Children In The United States And Those Traveling Internationally 6 Months And Older Are Current On MMR Vaccination
Benzinga · 12h ago
SCHD: Reconstitution But Familiar Names Remain, Still Generating Additional 'Income'
Schwab U.S. Dividend Equity ETF™ recently underwent its annual reconstitution. The fund provides exposure to a value-oriented portfolio and has delivered an attractive yield of 3.77%. Many familiar names remain in the fund's top ten, including Coca-Cola and Pfizer.
Seeking Alpha · 12h ago
SCHD's Reconstitution Adds Too Many Stocks With Mediocre Quant Ratings
The Schwab U.S. Dividend Equity ETF has eliminated and replaced 23 stocks contributing 1/5 of its dividend. Four of the added stocks are flagged as very risky by Seeking Alpha's Quant rating system. Broadcom and Merck were eliminated from the SCHD's top 10 largest holding.
Seeking Alpha · 14h ago
US Prescriptions Race For Weight Loss Drugs - Eli Lilly's Zepbound Overtakes Novo Nordisk's Wegovy
Eli Lilly And Co’s weight-loss drug Zepbound surged ahead with 77,590 new prescriptions in the U.S. For the week ending March 8. The drug surpassed rival obesity medicine Wegovy for the first time since its launch in December. The GLP-1 drugs are on track to surpass cancer immunotherapies as the best-selling medicines.
Benzinga · 16h ago
Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK) and Legend Biotech (LEGN)
TipRanks · 18h ago
Validea Detailed Fundamental Analysis - MRK
NASDAQ · 18h ago
More Big Changes To My Dividend Growth Portfolio
Home Dividends Analysis Dividend Strategy More Big Changes To My Dividending Growth Portfolio. Nicholas Ward has been actively reshaping his portfolio by selling off low-conviction holdings. He has reduced his holdings from 90 to 70 in the past 6 months. Ward believes his changes will set up his portfolio for continued double-digit income growth.
Seeking Alpha · 19h ago
More
About MRK
Merck & Co., Inc. is a global healthcare company. The Company offers health solutions through its prescription medicines, including biological therapies, vaccines and animal health products. The Company’s Pharmaceutical segment includes human health pharmaceutical and vaccine products. Its human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription for the treatment of human disorders. It sells human health pharmaceutical products to drug wholesalers and retailers, hospitals, government agencies and managed healthcare providers. The Company’s Animal Health segment develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products as well as health management solutions for the prevention, treatment and control of disease in all livestock and companion animal species. The Company’s product MK-7240 is used for the treatment of immune-mediated diseases including ulcerative colitis, and Crohn’s disease.

Webull offers Merck & Co Inc stock information, including NYSE: MRK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MRK stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MRK stock methods without spending real money on the virtual paper trading platform.